AIHW logo

METEOR logo

Our sites
AIHW GEN Aged Care Data Aboriginal and Torres Strait Islander
Health Performance Framework
Indigenous Mental Health and
Suicide Prevention Clearinghouse
Australian Mesothelioma Registry Housing data Regional Insights for Indigenous Communities
Contact FAQs

Site Navigation

  • Find metadata
    • Find metadata
    • Getting started
    • Data set specifications
    • Indicator sets
    • Data quality statements
    • Data dictionary archives
  • Metadata management
    • Metadata management
    • Data standards
    • Registration authorities
    • Registration statuses
  • How to use METEOR
    • How to use METEOR
    • First steps
    • Using My Page
    • Downloading and printing
    • FAQs
    • About METEOR
  • Learn about metadata
    • Learn about metadata
    • Metadata explained
    • How to create metadata
    • Metadata development resources
Your session is about to end!
Your session will expire at [TIME]
Select Extend at the top right corner or you will be logged out
National Health Performance Framework  >  Domain 1- Health status  >  Health conditions

Health conditions

Identifying and definitional attributes

Item type:Help on this termFramework Dimension
METEOR identifier:Help on this term392574
Description:Help on this termPrevalence of disease, disorder, injury or trauma or other health-related states.

Indicators in this framework

  • National Healthcare Agreement: P04-Incidence of selected cancers, 2010
            Health, Superseded 08/06/2011
  • National Healthcare Agreement: P03-Incidence of end-stage kidney disease, 2010
            Health, Superseded 08/06/2011
  • National Healthcare Agreement: P63-Children's hearing loss, 2010
            Health, Superseded 08/06/2011
  • National Healthcare Agreement: P01-Proportion of babies born with low birth weight, 2010
            Health, Superseded 08/06/2011
  • National Healthcare Agreement: PB 01-Reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) within 15 years (Baseline specification), 2011
            Health, Superseded 30/10/2011
  • National Healthcare Agreement: P02-Incidence of sexually transmitted infections and blood-borne viruses, 2010
            Health, Superseded 08/06/2011
  • National Healthcare Agreement: PI 02-Incidence of sexually transmissible infections and blood-borne viruses, 2011
            Health, Superseded 30/10/2011
  • National Healthcare Agreement: PI 03-Incidence of end-stage kidney disease, 2011
            Health, Superseded 30/10/2011
  • National Healthcare Agreement: PI 04-Incidence of selected cancers, 2011
            Health, Superseded 30/10/2011
  • National Healthcare Agreement: PB 01-Reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) within 15 years (Baseline specification), 2012
            Health, Superseded 25/06/2013
  • National Healthcare Agreement: PI 63-Children's hearing loss, 2012
            Health, Retired 25/06/2013
  • National Healthcare Agreement: PI 02-Incidence of sexually transmissible infections and blood-borne viruses, 2012
            Health, Retired 25/06/2013
  • National Healthcare Agreement: PI 03-Incidence of end-stage kidney disease, 2012
            Health, Retired 25/06/2013
  • National Healthcare Agreement: PI 04-Incidence of selected cancers, 2012
            Health, Superseded 25/06/2013
  • National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2013
            Health, Superseded 30/04/2014
  • National Healthcare Agreement: PI 02-Incidence of selected cancers, 2013
            Health, Superseded 30/04/2014
  • National Healthcare Agreement: PI 02-Incidence of selected cancers, 2014
            Health, Superseded 14/01/2015
  • National Healthcare Agreement: PI 02-Incidence of selected cancers, 2015
            Health, Superseded 08/07/2016
  • National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2015
            Health, Superseded 08/07/2016
  • National Healthcare Agreement: PB c-Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2014
            Health, Superseded 14/01/2015
  • National Healthcare Agreement: PI 63-Children's hearing loss, 2011
            Health, Superseded 31/10/2011
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2016
            Health, Superseded 31/01/2017
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2016
            Health, Superseded 31/01/2017
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2017
            Health, Superseded 30/01/2018
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2017
            Health, Superseded 30/01/2018
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2018
            Health, Superseded 19/06/2019
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2018
            Health, Superseded 19/06/2019
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2019
            Health, Superseded 13/03/2020
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2019
            Health, Superseded 13/03/2020
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2020
            Health, Standard 13/03/2020
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2020
            Health, Standard 13/03/2020
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2021
            Health, Standard 03/07/2020
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2021
            Health, Standard 16/09/2020
  • National Healthcare Agreement: PB c–Better health: reduce the age-adjusted prevalence rate for Type 2 diabetes to 2000 levels (equivalent to a national prevalence rate (for 25 years and over) of 7.1 per cent) by 2023, 2022
            Health, Standard 24/09/2021
  • National Healthcare Agreement: PI 02–Incidence of selected cancers, 2022
            Health, Standard 24/09/2021

<Title>

<body>
<footer>

View

  • Print view

Download

  • Word
  • PDF
  • Advanced options

Review

  • Compare items
Help
Downloading

The download may take a while, please wait.

Do not refresh the screen until the download is complete.

Terms & Conditions
Do you agree with the Terms and Conditions?

<Title>

<body>
<footer>
Loading...

Navigation

  • Find metadata
  • Metadata management
  • How to use METEOR
  • Learn about metadata

Resources

  • Accessibility
  • Copyright
  • Disclaimer
  • Freedom of Information
  • Privacy policy
  • Vulnerability and disclosure policy

Quick Links

  • Contact
  • FAQs
  • Search
AIHW logo
© Australian Insitute of Health and Welfware, 2023